{
    "pmcid": "10445546",
    "qa_pairs": {
        "How does the study propose to address the challenge of cross-reactivity with different SARS-CoV-2 variants?": [
            "By screening nanobodies for cross-reactivity with different spike protein variants.",
            "By designing nanobodies that only bind to a single variant of the spike protein.",
            "By using chemical modifications to alter nanobody specificity post-production.",
            "By focusing on non-structural proteins of the virus instead of the spike protein."
        ],
        "What is a key characteristic of nanobodies that makes them suitable for targeting complex proteins like the SARS-CoV-2 spike protein?": [
            "Their ability to bind to unique conformational epitopes.",
            "Their large size and complex structure.",
            "Their ability to integrate into host cell membranes.",
            "Their high rate of mutation and variability."
        ],
        "What is emphasized as critical for therapeutic applications of nanobodies in the study?": [
            "High stability and low non-specific binding.",
            "High immunogenicity and rapid degradation.",
            "Complex glycosylation patterns and large size.",
            "High mutation rate and low binding affinity."
        ],
        "What is the primary focus of the paper titled 'Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates'?": [
            "Development of nanobodies that specifically recognize aggregated forms of the tau protein.",
            "Investigation of the genetic mutations in tau protein associated with Alzheimer's.",
            "Analysis of the biochemical pathways involved in tau protein aggregation.",
            "Development of small molecules to inhibit tau protein aggregation."
        ],
        "Which method is used in the study to select nanobodies with high conformational specificity for tau aggregates?": [
            "Quantitative flow cytometry.",
            "Mass spectrometry.",
            "Western blotting.",
            "ELISA (Enzyme-Linked Immunosorbent Assay)."
        ]
    }
}